Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials

Yuki Matsuda, Taro Kishi, Nakao Iwata

Research output: Contribution to journalLetter

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)2018-2020
Number of pages3
JournalJournal of Psychiatric Research
Volume47
Issue number12
DOIs
Publication statusPublished - 01-01-2013

Fingerprint

Memantine
Amantadine
N-Methyl-D-Aspartate Receptors
Antipsychotic Agents
Meta-Analysis
Schizophrenia
Randomized Controlled Trials
Placebos
Safety
Therapeutics
Augmentation
Controlled
Placebo
Meta-analysis
Efficacy
Therapy
Antagonist

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

@article{3d77c0320ea64013a6bea5e74c1e796d,
title = "Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials",
author = "Yuki Matsuda and Taro Kishi and Nakao Iwata",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.jpsychires.2013.09.002",
language = "English",
volume = "47",
pages = "2018--2020",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia

T2 - An updated meta-analysis of randomized placebo-controlled trials

AU - Matsuda, Yuki

AU - Kishi, Taro

AU - Iwata, Nakao

PY - 2013/1/1

Y1 - 2013/1/1

UR - http://www.scopus.com/inward/record.url?scp=84886102138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886102138&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2013.09.002

DO - 10.1016/j.jpsychires.2013.09.002

M3 - Letter

C2 - 24079776

AN - SCOPUS:84886102138

VL - 47

SP - 2018

EP - 2020

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

IS - 12

ER -